Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18249
Title: Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma.
Authors: Crozier, Jack;Papa, Nathan P;Perera, Marlon;Stewart, Michael;Goad, Jeremy;Sengupta, Shomik;Bolton, Damien M;Lawrentschuk, Nathan L
Affiliation: Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
St Vincent's Hospital, Melbourne, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
Issue Date: Nov-2017
EDate: 2017-10-23
Citation: Investigative and clinical urology 2017; 58(6): 416-422
Abstract: To determine the oncological implications of increased nodal dissection in node-negative bladder cancer during radical cystectomy in a contemporary Australian series. We performed a multicenter retrospective study, including more than 40 surgeons across 5 sites over a 10-year period. We identified 353 patients with primary bladder cancer undergoing radical cystectomy. Extent of lymphadenectomy was defined as follows; limited pelvic lymph node dissection (PLND) (perivesical, pelvic, and obturator), standard PLND (internal and external iliac) and extended PLND (common iliac). Multivariable cox proportional hazards and logistic regression models were used to determine LNY effect on cancer-specific survival. Over the study period, the extent of dissection and lymph node yield increased considerably. In node-negative patients, lymph node yield (LNY) conferred a significantly improved cancer-specific survival. Compared to cases where LNY of 1 to 5 nodes were taken, the hazard ratio (HR) for 6 to 15 nodes harvested was 0.78 (95% confidence interval [CI], 0.43-1.39) and for greater than 15 nodes the HR was 0.31 (95% CI, 0.17-0.57), adjusted for age, sex, T stage, margin status, and year of surgery. The predicted probability of cancer-specific death within 2 years of cystectomy was 16% (95% CI, 13%-19%) with 10 nodes harvested, falling to 5.5% (95% CI, 0%-12%) with 30 nodes taken. Increasing harvest in all PLND templates conferred a survival benefit. The findings of the current study highlight the improved oncological outcomes with increased LNY, irrespective of the dissection template. Further prospective research is needed to aid LND data interpretation.
URI: http://ahro.austin.org.au/austinjspui/handle/1/18249
DOI: 10.4111/icu.2017.58.6.416
ORCID: 0000-0002-3188-1803
0000-0002-1138-6389
0000-0003-3357-1216
0000-0002-5145-6783
0000-0001-8553-5618
PubMed URL: 29124240
Type: Journal Article
Multicenter Study
Subjects: Lymph node excision
Neoplasm staging
Survival
Urinary bladder neoplasms
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.